Data for: A comparison of DFO and DFO* conjugated to trastuzumab-DM1 for complexing 89Zr – MicroPET/CT imaging in NOD/SCID mice with HER2-positive SK-OV-3 human ovarian cancer xenografts

Supporting Information for: Cho H, Al-saden N, Lam H, Mobus J, Reilly RM, Winnik MA. A comparison of DFO and DFO* conjugated to trastuzumab-DM1 for complexing 89Zr – In vitro stability and in vivo microPET/CT imaging studies in NOD/SCID mice with HER2-positive SK-OV-3 human ovarian cancer xenografts. Nucl. Med. Biol. (submitted) September 18, 2019.